Literature DB >> 12477361

Water stability and cytotoxic activity relationship of a series of ferrocenium derivatives. ESR insights on the radical production during the degradation process.

Giovanni Tabbì1, Claudio Cassino, Giorgio Cavigiolio, Donato Colangelo, Annalisa Ghiglia, Ilario Viano, Domenico Osella.   

Abstract

The cytotoxicity of some ferrocenium salts and the lack of activity of the corresponding ferrocenes has been already demonstrated. The cytotoxic activity in different conditions of decamethylferrocenium tetrafluoroborate (DEMFc(+)) in comparison with four other ferrocenium derivatives on MCF-7 cell line is reported. The relative stability in aqueous solutions with different buffering agents is investigated by means of UV-vis spectroscopy and correlated to the cytotoxic properties of the compounds. DEMFc(+), the most stable compound, shows the highest efficiency in inhibiting cell growth (IC(50) 35 microM, for 48 h treatment). Relaxation time measurements point out the involvement of water molecules in the degradation process. ESR results confirm the ability of ferrocenium cations to produce oxygen radical species as a consequence of their degradation in water. Oxygen-dependent formation of both hydroxyl and superoxide radicals is established by the spin-trapping technique. A direct evidence of the DEMFc(+) radical production into the viable cells is obtained by means of fluorescence-activated cell sorter (FACS) analysis that reveals a dose-dependent growth of 8-oxoguanine, the initial product of the guanine oxidation. This DNA oxidative stress justifies the cytotoxic effect of DEMFc(+). Furthermore, the cytotoxic cooperative effect of bleomycin, an iron-dependent antitumor drug, and DEMFc(+) has been tested. We have demonstrated the synergic effect between the two drugs, that is explained by the complementary oxidative damage inflicted to DNA as well as by the increasing of bleomycin activation by the iron(II/III) species available in the cell compartment from ferrocenium degradation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12477361     DOI: 10.1021/jm021003k

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  11 in total

1.  Synthesis, characterization and cytotoxic studies of water soluble [(η-C(5)H(5))(2)Mo(thionucleobase/thionucleoside)]Cl complexes in breast and colon cancer cell lines.

Authors:  Débora Acevedo-Acevedo; Jaime Matta; Enrique Meléndez
Journal:  J Organomet Chem       Date:  2011-03-01       Impact factor: 2.369

2.  Vectorized ferrocenes with estrogens and vitamin D2: synthesis, cytotoxic activity and docking studies.

Authors:  José Vera; Li Ming Gao; Alberto Santana; Jaime Matta; Enrique Meléndez
Journal:  Dalton Trans       Date:  2011-08-18       Impact factor: 4.390

3.  Ferrocenes as potential chemotherapeutic drugs: synthesis, cytotoxic activity, reactive oxygen species production and micronucleus assay.

Authors:  Wanda I Pérez; Yarelys Soto; Carmen Ortíz; Jaime Matta; Enrique Meléndez
Journal:  Bioorg Med Chem       Date:  2014-12-19       Impact factor: 3.641

Review 4.  Scope of organometallic compounds based on transition metal-arene systems as anticancer agents: starting from the classical paradigm to targeting multiple strategies.

Authors:  Mehvash Zaki; Suboot Hairat; Elham S Aazam
Journal:  RSC Adv       Date:  2019-01-24       Impact factor: 4.036

5.  Functionalized ferrocenes: The role of the para substituent on the phenoxy pendant group.

Authors:  José L Vera; Jorge Rullán; Natasha Santos; Jesús Jiménez; Joshua Rivera; Alberto Santana; Jon Briggs; Arnold L Rheingold; Jaime Matta; Enrique Meléndez
Journal:  J Organomet Chem       Date:  2014-01-01       Impact factor: 2.369

6.  Metallocenes as Target Specific Drugs for Cancer Treatment.

Authors:  Enrique Meléndez
Journal:  Inorganica Chim Acta       Date:  2012-06-21       Impact factor: 2.545

Review 7.  Organometallic anticancer compounds.

Authors:  Gilles Gasser; Ingo Ott; Nils Metzler-Nolte
Journal:  J Med Chem       Date:  2010-11-15       Impact factor: 7.446

8.  Crystal structure of bis-[4-(1H-pyrrol-1-yl)phen-yl] ferrocene-1,1'-di-carboxyl-ate: a potential chemotherapeutic drug.

Authors:  Wanda I Pérez; Arnold L Rheingold; Enrique Meléndez
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-04-22

9.  Targeting Antioxidant Pathways with Ferrocenylated N-Heterocyclic Carbene Supported Gold(I) Complexes in A549 Lung Cancer Cells.

Authors:  J F Arambula; R McCall; K J Sidoran; D Magda; N A Mitchell; C W Bielawski; V M Lynch; J L Sessler; K Arumugam
Journal:  Chem Sci       Date:  2015-10-29       Impact factor: 9.825

10.  Synthesis, structure, electrochemistry, and cytotoxic properties of ferrocenyl ester derivatives.

Authors:  Li Ming Gao; Ramón Hernández; Jaime Matta; Enrique Meléndez
Journal:  Met Based Drugs       Date:  2009-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.